Exelixis (EXEL) Current Deferred Revenue (2010 - 2023)

Exelixis (EXEL) recorded quarterly Current Deferred Revenue of $13.5 million in Q2 2023, up 1.21% quarter-over-quarter from $13.4 million in Q1 2023, and down 8.13% on a YoY basis from $14.7 million in Q2 2022.

Exelixis (EXEL) Current Deferred Revenue (2010 - 2023) Analysis & Trends

Exelixis' Current Deferred Revenue history runs 14 years deep, the most recent figure standing at $13.5 million for Q2 2023.

  • In Q2 2023, Current Deferred Revenue fell 8.13% year-over-year to $13.5 million; the TTM figure through Jun 2023 stood at $13.5 million (down 8.13% YoY), while the FY2022 annual figure was $14.1 million, down 15.0% from the prior year.
  • Current Deferred Revenue was $13.5 million for Q2 2023 at Exelixis, up from $13.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $19.0 million in Q2 2021 to a low of $321000.0 in Q2 2019.
  • Historically, Current Deferred Revenue has averaged $12.1 million across 5 years, with a median of $13.8 million in 2022.
  • The sharpest annual moves came in 2019 and 2020: Current Deferred Revenue sank 94.6% in 2019, then soared 4977.88% in 2020.
  • A 5-year view of Current Deferred Revenue shows it stood at $8.2 million in 2019, then climbed by 29.27% to $10.6 million in 2020, then jumped by 56.16% to $16.6 million in 2021, then dropped by 15.0% to $14.1 million in 2022, then dropped by 3.87% to $13.5 million in 2023.
  • The last three Current Deferred Revenue figures came in at $13.5 million (Q2 2023), $13.4 million (Q1 2023), and $14.1 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn -
6 Evaxion A 1,536.68 Bn 1,536.67 Bn -
7 Psyence Biomedical 238.34 Bn 238.33 Bn -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn
9 Abivax 95.45 Bn 95.45 Bn -
10 Exelixis 13.71 Bn 12.93 Bn 590.86 Mn

Historic Data

Download Data
DateValue
Jun 30, 2023 13.53 Mn
Mar 31, 2023 13.36 Mn
Dec 30, 2022 14.07 Mn
Sep 30, 2022 13.42 Mn
Jul 1, 2022 14.72 Mn
Apr 1, 2022 15.38 Mn
Dec 31, 2021 16.55 Mn
Oct 1, 2021 16.98 Mn
Jul 2, 2021 14.89 Mn
Apr 2, 2021 18.97 Mn
Jan 1, 2021 5.55 Mn
Oct 2, 2020 10.60 Mn
Jul 3, 2020 16.30 Mn
Apr 3, 2020 15.40 Mn
Jan 3, 2020 6.60 Mn
Sep 27, 2019 8.20 Mn
Jun 28, 2019 321,000.00
Mar 29, 2019 2.38 Mn
Dec 28, 2018 18.00 Mn
Jun 29, 2018 5.94 Mn